158 related articles for article (PubMed ID: 28171829)
1. Prevalence of false-positive hepatitis C antibody results, National Health and Nutrition Examination Study (NHANES) 2007-2012.
Moorman AC; Drobenuic J; Kamili S
J Clin Virol; 2017 Apr; 89():1-4. PubMed ID: 28171829
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of hepatitis C virus infection among human immunodeficiency virus-1-infected pregnant women in Malawi: the BAN study.
Chasela CS; Wall P; Drobeniuc J; King CC; Teshale E; Hosseinipour MC; Ellington SR; Codd M; Jamieson DJ; Knight RJ; Fitzpatrick P; Kourtis AP; Hoffman IF; Kayira D; Mumba N; Kamwendo DD; Martinson F; Powderly W; van der Horst C; Kamili S;
J Clin Virol; 2012 Aug; 54(4):318-20. PubMed ID: 22658797
[TBL] [Abstract][Full Text] [Related]
3. Indeterminate third-generation hepatitis C recombinant immunoblot assay and HCV RNA analysis: isolated reactivity against NS5 associated with HCV viraemia in clinical patients but not blood donors.
Cavazza S; Lagging M
Scand J Infect Dis; 2005; 37(6-7):488-92. PubMed ID: 16012009
[TBL] [Abstract][Full Text] [Related]
4. Performance of hepatitis C virus (HCV) antibody test systems in relation to HCV-RNA detection in the diagnosis of HCV infection.
Krarup HB; Jacobsen SE; Varming K; Drewes AM; Madsen PH
Dan Med Bull; 1998 Feb; 45(1):89-91. PubMed ID: 9504268
[TBL] [Abstract][Full Text] [Related]
5. Characterization of differential antibody production against hepatitis C virus in different HCV infection status.
Rafik M; Bakr S; Soliman D; Mohammed N; Ragab D; ElHady WA; Samir N
Virol J; 2016 Jun; 13():116. PubMed ID: 27357382
[TBL] [Abstract][Full Text] [Related]
6. Low-positive anti-hepatitis C virus enzyme immunoassay results: an important predictor of low likelihood of hepatitis C infection.
Dufour DR; Talastas M; Fernandez MD; Harris B; Strader DB; Seeff LB
Clin Chem; 2003 Mar; 49(3):479-86. PubMed ID: 12600961
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Quantitative Real-Time PCR as a Hepatitis C Virus Supplementary Test After RIBA Discontinuation.
Gong S; Schmotzer CL; Zhou L
J Clin Lab Anal; 2016 Sep; 30(5):418-23. PubMed ID: 26499369
[TBL] [Abstract][Full Text] [Related]
8. The clinical relevance of persistent recombinant immunoblot assay-indeterminate reactions: insights into the natural history of hepatitis C virus infection and implications for donor counseling.
Makuria AT; Raghuraman S; Burbelo PD; Cantilena CC; Allison RD; Gibble J; Rehermann B; Alter HJ
Transfusion; 2012 Sep; 52(9):1940-8. PubMed ID: 22304422
[TBL] [Abstract][Full Text] [Related]
9. [Guideline for interpretation and report of the antibody to hepatitis C virus. Grupo de Desarrollo de la Guía ].
Contreras AM; Ochoa-Jiménez RJ; Kershenobich D; Granados-García V; Conde-González CJ; Celis A; Pérez-Gómez HR; Ruelas-Hernández S; Romero-Flores P; Alcántar-Luna E; Sierra-García de Quevedo J; Ancona-Pisté O;
Rev Invest Clin; 2012; 64(6 Pt 2):641-78. PubMed ID: 23593783
[TBL] [Abstract][Full Text] [Related]
10. False-positive hepatitis C virus serology after placement of a ventricular assistance device.
Durand CM; Marr KA; Ostrander D; Subramanian A; Valsamakis A; Cox A; Neofytos D
Transpl Infect Dis; 2016 Feb; 18(1):146-9. PubMed ID: 26565742
[TBL] [Abstract][Full Text] [Related]
11. [Application of anti-HCV and HCV RNA detection in intravenous drug users].
Xu B; Chen B; Ma ZH; Ren YN; Ma JQ; Pei LJ; Xing WW
Zhonghua Gan Zang Bing Za Zhi; 2021 May; 29(5):415-420. PubMed ID: 34107577
[No Abstract] [Full Text] [Related]
12. Significance of highly positive c22-3 "indeterminate" second-generation hepatitis C virus (HCV) recombinant immunoblot assay (RIBA) and resolution by third-generation HCV RIBA.
Pawlotsky JM; Fleury A; Choukroun V; Deforges L; Roudot-Thoraval F; Aumont P; Duval J; Dhumeaux D
J Clin Microbiol; 1994 May; 32(5):1357-9. PubMed ID: 7519631
[TBL] [Abstract][Full Text] [Related]
13. The Role of the Signal-to-Cutoff Ratio in Automated Anti-HCV Chemiluminescent Immunoassays by Referring to the Nucleic Acid Amplification Test and the Recombinant Immunoblot Assay.
Choi MS; Lee K; Hong YJ; Song EY; Kim DS; Song J
Ann Lab Med; 2018 Sep; 38(5):466-472. PubMed ID: 29797818
[TBL] [Abstract][Full Text] [Related]
14. Reflex threshold of signal-to-cut-off ratios of the Elecsys anti-HCV II assay for hepatitis C virus infection.
Pan J; Li X; He G; Yuan S; Feng P; Zhang X; Qiu Y
J Infect Dev Ctries; 2016 Sep; 10(9):1031-1034. PubMed ID: 27694738
[TBL] [Abstract][Full Text] [Related]
15. [Anti-HCV serology for screening, diagnosis and surveillance of hepatitis C: role of the immunoblot].
Dubois F; Barin F; Goudeau A
Ann Biol Clin (Paris); 1998; 56(4):417-26. PubMed ID: 9754277
[TBL] [Abstract][Full Text] [Related]
16. Epidemiological, biological and histological characterization of patients with indeterminate third-generation recombinant immunoblot assay antibody results for hepatitis C virus.
Ríos M; Diago M; Rivera P; Tuset C; Cors R; García V; Carbonel P; Gonzalez C
J Viral Hepat; 2006 Mar; 13(3):177-81. PubMed ID: 16475993
[TBL] [Abstract][Full Text] [Related]
17. Indeterminate RIBA results were associated with the absence of hepatitis C virus RNA (HCV-RNA) in blood donors.
Pereira FM; Zarife MA; Reis EA; G Reis M
Rev Soc Bras Med Trop; 2014; 47(1):12-7. PubMed ID: 24603731
[TBL] [Abstract][Full Text] [Related]
18. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy.
Guadagnino V; Stroffolini T; Rapicetta M; Costantino A; Kondili LA; Menniti-Ippolito F; Caroleo B; Costa C; Griffo G; Loiacono L; Pisani V; Focà A; Piazza M
Hepatology; 1997 Oct; 26(4):1006-11. PubMed ID: 9328327
[TBL] [Abstract][Full Text] [Related]
19. One or two serological assay testing strategy for diagnosis of HBV and HCV infection? The use of predictive modelling.
Parry JV; Easterbrook P; Sands AR
BMC Infect Dis; 2017 Nov; 17(Suppl 1):705. PubMed ID: 29143611
[TBL] [Abstract][Full Text] [Related]
20. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.
Conry-Cantilena C; VanRaden M; Gibble J; Melpolder J; Shakil AO; Viladomiu L; Cheung L; DiBisceglie A; Hoofnagle J; Shih JW
N Engl J Med; 1996 Jun; 334(26):1691-6. PubMed ID: 8637513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
